Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS)

• Samuel Yeroushalmi, BS,
• Mimi Chung, BA,
• Erin Bartholomew, BA,
• Marwa Hakimi, MD,
• John Koo, MD

Affiliations

Samuel Yeroushalmi, BS

Correspondence to: Samuel Yeroushalmi, BS, 515 Spruce St, San Francisco, CA 94118; Department of Dermatology, University of California, San Francisco, San Francisco, California

Mimi Chung, BA

Department of Dermatology, University of California, San Francisco, San Francisco, California

Erin Bartholomew, BA

Department of Dermatology, University of California, San Francisco, San Francisco, California

Marwa Hakimi, MD

Department of Dermatology, University of California, San Francisco, San Francisco, California

John Koo, MD

Department of Dermatology, University of California, San Francisco, San Francisco, California